Literature DB >> 15265674

Behavioral testing strategies in a localized animal model of multiple sclerosis.

Bigna S Buddeberg1, Martin Kerschensteiner, Doron Merkler, Christine Stadelmann, Martin E Schwab.   

Abstract

To assess neurological impairments quantitatively in an animal model of multiple sclerosis (MS), we have used a targeted model of experimental autoimmune encephalomyelitis (EAE), which leads to the formation of anatomically defined lesions in the spinal cord. Deficits in the hindlimb locomotion are therefore well defined and highly reproducible, in contrast to the situation in generalized EAE with disseminated lesions. Behavioral tests for hindlimb sensorimotor functions, originally established for traumatic spinal cord injury, revealed temporary or persistent deficits in open field locomotion, the grid walk, the narrow beam and the measurement of the foot exorotation angle. Such refined behavioral testing in EAE will be crucial for the analysis of new therapeutic approaches for MS that seek to improve or prevent neurological impairment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265674     DOI: 10.1016/j.jneuroim.2004.05.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

1.  Apyrase and 5'-nucleotidase activities in synaptosomes from the cerebral cortex of rats experimentally demyelinated with ethidium bromide and treated with interferon-beta.

Authors:  R M M Spanevello; C M Mazzanti; R Kaizer; R Zanin; D Cargnelutti; L Hannel; M Côrrea; A Mazzanti; R Festugatto; D Graça; M R C Schetinger; V M Morsch
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

2.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

3.  Protective Effects of Leukadherin1 in a Rat Model of Targeted Experimental Autoimmune Encephalomyelitis (EAE): Possible Role of P47phox and MDA Downregulation.

Authors:  Sara Hemmati; Mohammad Amin Sadeghi; Hasan Yousefi-Manesh; Mostafa Eslamiyeh; Ali Vafaei; Laleh Foroutani; Ghazaleh Donyadideh; AhmadReza Dehpour; Nima Rezaei
Journal:  J Inflamm Res       Date:  2020-07-31

4.  A CB2 Receptor Agonist Reduces the Production of Inflammatory Mediators and Improves Locomotor Activity in Experimental Autoimmune Encephalomyelitis.

Authors:  Karim Parastouei; Mohammad Hossein Aarabi; Gholam Ali Hamidi; Zahra Nasehi; Shima Kabiri-Arani; Faezeh Jozi; Mohammad Esmaeil Shahaboddin
Journal:  Rep Biochem Mol Biol       Date:  2022-04

5.  Angiogenesis induced by CNS inflammation promotes neuronal remodeling through vessel-derived prostacyclin.

Authors:  Rieko Muramatsu; Chisato Takahashi; Shuzo Miyake; Harutoshi Fujimura; Hideki Mochizuki; Toshihide Yamashita
Journal:  Nat Med       Date:  2012-10-07       Impact factor: 53.440

Review 6.  Developing therapeutics for the treatment of multiple sclerosis.

Authors:  David J Virley
Journal:  NeuroRx       Date:  2005-10

7.  Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice.

Authors:  Silvy Mardiguian; Sébastien Serres; Emma Ladds; Sandra J Campbell; Panop Wilainam; Charles McFadyen; Martina McAteer; Robin P Choudhury; Paul Smith; Fay Saunders; Gillian Watt; Nicola R Sibson; Daniel C Anthony
Journal:  Am J Pathol       Date:  2013-04-16       Impact factor: 4.307

8.  Anti-LINGO-1 improved remyelination and neurobehavioral deficit in cuprizone-induced demyelination.

Authors:  Khadijeh Moradbeygi; Mohsen Parviz; Hossein Rezaeizadeh; Arman Zargaran; Mohammad Ali Sahraian; Shima Mehrabadi; Marjan Nikbakhtzadeh; Elham Zahedi
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

Review 9.  Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Authors:  Bhasker Sriramoju; Rupinder K Kanwar; Jagat R Kanwar
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570

10.  Myelination- and immune-mediated MR-based brain network correlates.

Authors:  Manuela Cerina; Muthuraman Muthuraman; Marco Gallus; Nabin Koirala; Andre Dik; Lydia Wachsmuth; Petra Hundehege; Patrick Schiffler; Jan-Gerd Tenberge; Vinzenz Fleischer; Gabriel Gonzalez-Escamilla; Venu Narayanan; Julia Krämer; Cornelius Faber; Thomas Budde; Sergiu Groppa; Sven G Meuth
Journal:  J Neuroinflammation       Date:  2020-06-12       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.